本文選題：結(jié)核性腦膜炎 + 耐藥��； 參考：《華西醫(yī)學(xué)》2016年02期

【摘要】：目的分析耐藥結(jié)核性腦膜炎(TBM)的療效及預(yù)后。方法對(duì)2010年1月-2015年12月住院的32例成人耐藥TBM患者病歷資料進(jìn)行回顧性分析并電話(huà)隨訪(fǎng)了解患者的預(yù)后情況,采用改良Rankin量表(m RS)對(duì)預(yù)后進(jìn)行評(píng)分。結(jié)果 32例耐藥TBM患者中好轉(zhuǎn)31例(96.9%),治療無(wú)效死亡1例(3.1%)。治療后1例出現(xiàn)激素相關(guān)性青光眼及骨質(zhì)疏松,1例出現(xiàn)藥物性庫(kù)欣綜合征。27例(84.4%)患者m RS評(píng)分≤2分。結(jié)論耐藥TBM早期診斷困難,經(jīng)積極抗結(jié)核并輔助治療,療效滿(mǎn)意。
[Abstract]:Objective to analyze the curative effect and prognosis of drug resistant tuberculous meningitis (TBM). Methods the medical records of 32 adult TBM patients who were hospitalized from January 2010 to December 2015 were retrospectively analyzed and their prognosis was evaluated by modified Rankin scale (Mrs). Results among 32 patients with TBM, 31 cases (96.9%) were improved and 1 case (3.1%) died of ineffective treatment. After treatment, one patient developed hormone associated glaucoma and one patient with osteoporosis developed drug-induced Cushing syndrome. 27 patients (84.4%) had MRS 鈮，

本文編號(hào)：2079388